nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—Mesalazine—PPARG—colon cancer	0.00966	0.703	CrCbGaD
Carbidopa—Mesalazine—PTGS2—colon cancer	0.00408	0.297	CrCbGaD
Carbidopa—Haemorrhage—Irinotecan—colon cancer	0.00342	0.00346	CcSEcCtD
Carbidopa—Agranulocytosis—Fluorouracil—colon cancer	0.0034	0.00345	CcSEcCtD
Carbidopa—Hyponatraemia—Capecitabine—colon cancer	0.00332	0.00337	CcSEcCtD
Carbidopa—Diplopia—Capecitabine—colon cancer	0.00331	0.00335	CcSEcCtD
Carbidopa—Pain in extremity—Capecitabine—colon cancer	0.00331	0.00335	CcSEcCtD
Carbidopa—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.00331	0.00335	CcSEcCtD
Carbidopa—Haemoglobin—Fluorouracil—colon cancer	0.00329	0.00334	CcSEcCtD
Carbidopa—Rhinitis—Fluorouracil—colon cancer	0.00328	0.00333	CcSEcCtD
Carbidopa—Disturbance in sexual arousal—Capecitabine—colon cancer	0.00328	0.00333	CcSEcCtD
Carbidopa—Haemorrhage—Fluorouracil—colon cancer	0.00327	0.00332	CcSEcCtD
Carbidopa—Hypoaesthesia—Fluorouracil—colon cancer	0.00326	0.0033	CcSEcCtD
Carbidopa—Flushing—Irinotecan—colon cancer	0.00317	0.00322	CcSEcCtD
Carbidopa—Urinary retention—Capecitabine—colon cancer	0.00314	0.00319	CcSEcCtD
Carbidopa—Ataxia—Capecitabine—colon cancer	0.00311	0.00315	CcSEcCtD
Carbidopa—Alopecia—Vincristine—colon cancer	0.0031	0.00314	CcSEcCtD
Carbidopa—Blood creatinine increased—Capecitabine—colon cancer	0.0031	0.00314	CcSEcCtD
Carbidopa—Mental disorder—Vincristine—colon cancer	0.00307	0.00312	CcSEcCtD
Carbidopa—Alopecia—Irinotecan—colon cancer	0.00302	0.00306	CcSEcCtD
Carbidopa—Orthostatic hypotension—Capecitabine—colon cancer	0.00302	0.00306	CcSEcCtD
Carbidopa—Nasopharyngitis—Capecitabine—colon cancer	0.00296	0.003	CcSEcCtD
Carbidopa—Back pain—Vincristine—colon cancer	0.00295	0.003	CcSEcCtD
Carbidopa—Flatulence—Irinotecan—colon cancer	0.00293	0.00297	CcSEcCtD
Carbidopa—Gastritis—Capecitabine—colon cancer	0.00293	0.00297	CcSEcCtD
Carbidopa—Alopecia—Fluorouracil—colon cancer	0.00289	0.00293	CcSEcCtD
Carbidopa—Back pain—Irinotecan—colon cancer	0.00288	0.00292	CcSEcCtD
Carbidopa—Muscle spasms—Irinotecan—colon cancer	0.00286	0.0029	CcSEcCtD
Carbidopa—Dysphagia—Capecitabine—colon cancer	0.00286	0.0029	CcSEcCtD
Carbidopa—Anaemia—Vincristine—colon cancer	0.00282	0.00286	CcSEcCtD
Carbidopa—Agitation—Vincristine—colon cancer	0.00281	0.00285	CcSEcCtD
Carbidopa—Sweating increased—Capecitabine—colon cancer	0.00278	0.00282	CcSEcCtD
Carbidopa—Ill-defined disorder—Irinotecan—colon cancer	0.00276	0.0028	CcSEcCtD
Carbidopa—Anaemia—Irinotecan—colon cancer	0.00275	0.00279	CcSEcCtD
Carbidopa—Leukopenia—Vincristine—colon cancer	0.00273	0.00277	CcSEcCtD
Carbidopa—Vision blurred—Fluorouracil—colon cancer	0.00268	0.00272	CcSEcCtD
Carbidopa—Malaise—Irinotecan—colon cancer	0.00268	0.00272	CcSEcCtD
Carbidopa—Syncope—Irinotecan—colon cancer	0.00267	0.0027	CcSEcCtD
Carbidopa—Leukopenia—Irinotecan—colon cancer	0.00266	0.0027	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Capecitabine—colon cancer	0.00266	0.00269	CcSEcCtD
Carbidopa—Convulsion—Vincristine—colon cancer	0.00265	0.00268	CcSEcCtD
Carbidopa—Hypertension—Vincristine—colon cancer	0.00264	0.00267	CcSEcCtD
Carbidopa—Anaemia—Fluorouracil—colon cancer	0.00263	0.00267	CcSEcCtD
Carbidopa—Loss of consciousness—Irinotecan—colon cancer	0.00261	0.00265	CcSEcCtD
Carbidopa—Weight increased—Capecitabine—colon cancer	0.0026	0.00264	CcSEcCtD
Carbidopa—Cough—Irinotecan—colon cancer	0.0026	0.00263	CcSEcCtD
Carbidopa—Weight decreased—Capecitabine—colon cancer	0.00258	0.00262	CcSEcCtD
Carbidopa—Hypertension—Irinotecan—colon cancer	0.00257	0.0026	CcSEcCtD
Carbidopa—Leukopenia—Fluorouracil—colon cancer	0.00255	0.00259	CcSEcCtD
Carbidopa—Depression—Capecitabine—colon cancer	0.00254	0.00258	CcSEcCtD
Carbidopa—Acute coronary syndrome—Capecitabine—colon cancer	0.00251	0.00255	CcSEcCtD
Carbidopa—Discomfort—Irinotecan—colon cancer	0.0025	0.00254	CcSEcCtD
Carbidopa—Myocardial infarction—Capecitabine—colon cancer	0.0025	0.00253	CcSEcCtD
Carbidopa—Neuropathy peripheral—Capecitabine—colon cancer	0.0025	0.00253	CcSEcCtD
Carbidopa—Oedema—Vincristine—colon cancer	0.00249	0.00253	CcSEcCtD
Carbidopa—Infection—Vincristine—colon cancer	0.00248	0.00251	CcSEcCtD
Carbidopa—Urinary tract infection—Capecitabine—colon cancer	0.00248	0.00251	CcSEcCtD
Carbidopa—Convulsion—Fluorouracil—colon cancer	0.00247	0.0025	CcSEcCtD
Carbidopa—Confusional state—Irinotecan—colon cancer	0.00245	0.00248	CcSEcCtD
Carbidopa—Thrombocytopenia—Vincristine—colon cancer	0.00244	0.00247	CcSEcCtD
Carbidopa—Oedema—Irinotecan—colon cancer	0.00243	0.00246	CcSEcCtD
Carbidopa—Chest pain—Fluorouracil—colon cancer	0.00243	0.00246	CcSEcCtD
Carbidopa—Infection—Irinotecan—colon cancer	0.00241	0.00245	CcSEcCtD
Carbidopa—Hyperhidrosis—Vincristine—colon cancer	0.00241	0.00244	CcSEcCtD
Carbidopa—Discomfort—Fluorouracil—colon cancer	0.0024	0.00243	CcSEcCtD
Carbidopa—Shock—Irinotecan—colon cancer	0.00239	0.00242	CcSEcCtD
Carbidopa—Agranulocytosis—Capecitabine—colon cancer	0.00238	0.00241	CcSEcCtD
Carbidopa—Thrombocytopenia—Irinotecan—colon cancer	0.00238	0.00241	CcSEcCtD
Carbidopa—Anorexia—Vincristine—colon cancer	0.00238	0.00241	CcSEcCtD
Carbidopa—Hyperhidrosis—Irinotecan—colon cancer	0.00235	0.00238	CcSEcCtD
Carbidopa—Confusional state—Fluorouracil—colon cancer	0.00234	0.00238	CcSEcCtD
Carbidopa—Hypotension—Vincristine—colon cancer	0.00233	0.00236	CcSEcCtD
Carbidopa—Oedema—Fluorouracil—colon cancer	0.00233	0.00236	CcSEcCtD
Carbidopa—Anorexia—Irinotecan—colon cancer	0.00231	0.00235	CcSEcCtD
Carbidopa—Ataxia—Methotrexate—colon cancer	0.00231	0.00235	CcSEcCtD
Carbidopa—Infection—Fluorouracil—colon cancer	0.00231	0.00234	CcSEcCtD
Carbidopa—Haemoglobin—Capecitabine—colon cancer	0.0023	0.00233	CcSEcCtD
Carbidopa—Rhinitis—Capecitabine—colon cancer	0.00229	0.00232	CcSEcCtD
Carbidopa—Haemorrhage—Capecitabine—colon cancer	0.00229	0.00232	CcSEcCtD
Carbidopa—Thrombocytopenia—Fluorouracil—colon cancer	0.00228	0.00231	CcSEcCtD
Carbidopa—Hypoaesthesia—Capecitabine—colon cancer	0.00228	0.00231	CcSEcCtD
Carbidopa—Hypotension—Irinotecan—colon cancer	0.00227	0.0023	CcSEcCtD
Carbidopa—Urinary tract disorder—Capecitabine—colon cancer	0.00226	0.00229	CcSEcCtD
Carbidopa—Insomnia—Vincristine—colon cancer	0.00225	0.00229	CcSEcCtD
Carbidopa—Urethral disorder—Capecitabine—colon cancer	0.00224	0.00227	CcSEcCtD
Carbidopa—Paraesthesia—Vincristine—colon cancer	0.00224	0.00227	CcSEcCtD
Carbidopa—Anorexia—Fluorouracil—colon cancer	0.00222	0.00225	CcSEcCtD
Carbidopa—Insomnia—Irinotecan—colon cancer	0.0022	0.00223	CcSEcCtD
Carbidopa—Paraesthesia—Irinotecan—colon cancer	0.00218	0.00221	CcSEcCtD
Carbidopa—Hypotension—Fluorouracil—colon cancer	0.00217	0.0022	CcSEcCtD
Carbidopa—Decreased appetite—Vincristine—colon cancer	0.00217	0.0022	CcSEcCtD
Carbidopa—Dyspnoea—Irinotecan—colon cancer	0.00216	0.00219	CcSEcCtD
Carbidopa—Somnolence—Irinotecan—colon cancer	0.00216	0.00219	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Vincristine—colon cancer	0.00215	0.00218	CcSEcCtD
Carbidopa—Fatigue—Vincristine—colon cancer	0.00215	0.00218	CcSEcCtD
Carbidopa—Dyspepsia—Irinotecan—colon cancer	0.00214	0.00217	CcSEcCtD
Carbidopa—Constipation—Vincristine—colon cancer	0.00213	0.00216	CcSEcCtD
Carbidopa—Pain—Vincristine—colon cancer	0.00213	0.00216	CcSEcCtD
Carbidopa—Flushing—Capecitabine—colon cancer	0.00212	0.00215	CcSEcCtD
Carbidopa—Decreased appetite—Irinotecan—colon cancer	0.00211	0.00214	CcSEcCtD
Carbidopa—Insomnia—Fluorouracil—colon cancer	0.0021	0.00213	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Irinotecan—colon cancer	0.0021	0.00213	CcSEcCtD
Carbidopa—Fatigue—Irinotecan—colon cancer	0.00209	0.00212	CcSEcCtD
Carbidopa—Paraesthesia—Fluorouracil—colon cancer	0.00209	0.00212	CcSEcCtD
Carbidopa—Constipation—Irinotecan—colon cancer	0.00208	0.0021	CcSEcCtD
Carbidopa—Pain—Irinotecan—colon cancer	0.00208	0.0021	CcSEcCtD
Carbidopa—Dyspnoea—Fluorouracil—colon cancer	0.00207	0.0021	CcSEcCtD
Carbidopa—Somnolence—Fluorouracil—colon cancer	0.00207	0.0021	CcSEcCtD
Carbidopa—Dyspepsia—Fluorouracil—colon cancer	0.00205	0.00208	CcSEcCtD
Carbidopa—Gastrointestinal pain—Vincristine—colon cancer	0.00204	0.00207	CcSEcCtD
Carbidopa—Decreased appetite—Fluorouracil—colon cancer	0.00202	0.00205	CcSEcCtD
Carbidopa—Alopecia—Capecitabine—colon cancer	0.00202	0.00205	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00201	0.00204	CcSEcCtD
Carbidopa—Mental disorder—Capecitabine—colon cancer	0.002	0.00203	CcSEcCtD
Carbidopa—Feeling abnormal—Irinotecan—colon cancer	0.002	0.00203	CcSEcCtD
Carbidopa—Pain—Fluorouracil—colon cancer	0.00199	0.00202	CcSEcCtD
Carbidopa—Gastrointestinal pain—Irinotecan—colon cancer	0.00199	0.00201	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Methotrexate—colon cancer	0.00198	0.002	CcSEcCtD
Carbidopa—Body temperature increased—Vincristine—colon cancer	0.00197	0.002	CcSEcCtD
Carbidopa—Abdominal pain—Vincristine—colon cancer	0.00197	0.002	CcSEcCtD
Carbidopa—Flatulence—Capecitabine—colon cancer	0.00196	0.00199	CcSEcCtD
Carbidopa—Dysgeusia—Capecitabine—colon cancer	0.00195	0.00198	CcSEcCtD
Carbidopa—Back pain—Capecitabine—colon cancer	0.00193	0.00195	CcSEcCtD
Carbidopa—Abdominal pain—Irinotecan—colon cancer	0.00192	0.00195	CcSEcCtD
Carbidopa—Body temperature increased—Irinotecan—colon cancer	0.00192	0.00195	CcSEcCtD
Carbidopa—Feeling abnormal—Fluorouracil—colon cancer	0.00192	0.00194	CcSEcCtD
Carbidopa—Muscle spasms—Capecitabine—colon cancer	0.00191	0.00194	CcSEcCtD
Carbidopa—Depression—Methotrexate—colon cancer	0.00189	0.00192	CcSEcCtD
Carbidopa—Vision blurred—Capecitabine—colon cancer	0.00188	0.0019	CcSEcCtD
Carbidopa—Tremor—Capecitabine—colon cancer	0.00187	0.00189	CcSEcCtD
Carbidopa—Ill-defined disorder—Capecitabine—colon cancer	0.00185	0.00187	CcSEcCtD
Carbidopa—Urticaria—Fluorouracil—colon cancer	0.00185	0.00187	CcSEcCtD
Carbidopa—Anaemia—Capecitabine—colon cancer	0.00184	0.00187	CcSEcCtD
Carbidopa—Body temperature increased—Fluorouracil—colon cancer	0.00184	0.00186	CcSEcCtD
Carbidopa—Hypersensitivity—Vincristine—colon cancer	0.00184	0.00186	CcSEcCtD
Carbidopa—Malaise—Capecitabine—colon cancer	0.0018	0.00182	CcSEcCtD
Carbidopa—Hypersensitivity—Irinotecan—colon cancer	0.00179	0.00181	CcSEcCtD
Carbidopa—Asthenia—Vincristine—colon cancer	0.00179	0.00181	CcSEcCtD
Carbidopa—Syncope—Capecitabine—colon cancer	0.00179	0.00181	CcSEcCtD
Carbidopa—Leukopenia—Capecitabine—colon cancer	0.00178	0.00181	CcSEcCtD
Carbidopa—Agranulocytosis—Methotrexate—colon cancer	0.00177	0.00179	CcSEcCtD
Carbidopa—Palpitations—Capecitabine—colon cancer	0.00176	0.00178	CcSEcCtD
Carbidopa—Loss of consciousness—Capecitabine—colon cancer	0.00175	0.00177	CcSEcCtD
Carbidopa—Asthenia—Irinotecan—colon cancer	0.00174	0.00177	CcSEcCtD
Carbidopa—Cough—Capecitabine—colon cancer	0.00174	0.00176	CcSEcCtD
Carbidopa—Hypertension—Capecitabine—colon cancer	0.00172	0.00174	CcSEcCtD
Carbidopa—Hypersensitivity—Fluorouracil—colon cancer	0.00171	0.00174	CcSEcCtD
Carbidopa—Haemoglobin—Methotrexate—colon cancer	0.00171	0.00173	CcSEcCtD
Carbidopa—Diarrhoea—Vincristine—colon cancer	0.00171	0.00173	CcSEcCtD
Carbidopa—Haemorrhage—Methotrexate—colon cancer	0.0017	0.00173	CcSEcCtD
Carbidopa—Chest pain—Capecitabine—colon cancer	0.00169	0.00172	CcSEcCtD
Carbidopa—Anxiety—Capecitabine—colon cancer	0.00169	0.00171	CcSEcCtD
Carbidopa—Urinary tract disorder—Methotrexate—colon cancer	0.00168	0.0017	CcSEcCtD
Carbidopa—Discomfort—Capecitabine—colon cancer	0.00167	0.0017	CcSEcCtD
Carbidopa—Urethral disorder—Methotrexate—colon cancer	0.00167	0.00169	CcSEcCtD
Carbidopa—Diarrhoea—Irinotecan—colon cancer	0.00166	0.00168	CcSEcCtD
Carbidopa—Dry mouth—Capecitabine—colon cancer	0.00166	0.00168	CcSEcCtD
Carbidopa—Dizziness—Vincristine—colon cancer	0.00165	0.00167	CcSEcCtD
Carbidopa—Pruritus—Fluorouracil—colon cancer	0.00165	0.00167	CcSEcCtD
Carbidopa—Confusional state—Capecitabine—colon cancer	0.00164	0.00166	CcSEcCtD
Carbidopa—Oedema—Capecitabine—colon cancer	0.00162	0.00165	CcSEcCtD
Carbidopa—Infection—Capecitabine—colon cancer	0.00161	0.00164	CcSEcCtD
Carbidopa—Dizziness—Irinotecan—colon cancer	0.00161	0.00163	CcSEcCtD
Carbidopa—Shock—Capecitabine—colon cancer	0.0016	0.00162	CcSEcCtD
Carbidopa—Diarrhoea—Fluorouracil—colon cancer	0.00159	0.00161	CcSEcCtD
Carbidopa—Thrombocytopenia—Capecitabine—colon cancer	0.00159	0.00161	CcSEcCtD
Carbidopa—Vomiting—Vincristine—colon cancer	0.00158	0.00161	CcSEcCtD
Carbidopa—Rash—Vincristine—colon cancer	0.00157	0.00159	CcSEcCtD
Carbidopa—Hyperhidrosis—Capecitabine—colon cancer	0.00157	0.00159	CcSEcCtD
Carbidopa—Dermatitis—Vincristine—colon cancer	0.00157	0.00159	CcSEcCtD
Carbidopa—Headache—Vincristine—colon cancer	0.00156	0.00158	CcSEcCtD
Carbidopa—Anorexia—Capecitabine—colon cancer	0.00155	0.00157	CcSEcCtD
Carbidopa—Vomiting—Irinotecan—colon cancer	0.00154	0.00157	CcSEcCtD
Carbidopa—Dizziness—Fluorouracil—colon cancer	0.00154	0.00156	CcSEcCtD
Carbidopa—Rash—Irinotecan—colon cancer	0.00153	0.00155	CcSEcCtD
Carbidopa—Dermatitis—Irinotecan—colon cancer	0.00153	0.00155	CcSEcCtD
Carbidopa—Headache—Irinotecan—colon cancer	0.00152	0.00154	CcSEcCtD
Carbidopa—Hypotension—Capecitabine—colon cancer	0.00152	0.00154	CcSEcCtD
Carbidopa—Alopecia—Methotrexate—colon cancer	0.0015	0.00153	CcSEcCtD
Carbidopa—Mental disorder—Methotrexate—colon cancer	0.00149	0.00151	CcSEcCtD
Carbidopa—Nausea—Vincristine—colon cancer	0.00148	0.0015	CcSEcCtD
Carbidopa—Vomiting—Fluorouracil—colon cancer	0.00148	0.0015	CcSEcCtD
Carbidopa—Insomnia—Capecitabine—colon cancer	0.00147	0.00149	CcSEcCtD
Carbidopa—Rash—Fluorouracil—colon cancer	0.00147	0.00149	CcSEcCtD
Carbidopa—Dermatitis—Fluorouracil—colon cancer	0.00146	0.00149	CcSEcCtD
Carbidopa—Paraesthesia—Capecitabine—colon cancer	0.00146	0.00148	CcSEcCtD
Carbidopa—Headache—Fluorouracil—colon cancer	0.00146	0.00148	CcSEcCtD
Carbidopa—Dysgeusia—Methotrexate—colon cancer	0.00145	0.00147	CcSEcCtD
Carbidopa—Dyspnoea—Capecitabine—colon cancer	0.00145	0.00147	CcSEcCtD
Carbidopa—Nausea—Irinotecan—colon cancer	0.00144	0.00146	CcSEcCtD
Carbidopa—Back pain—Methotrexate—colon cancer	0.00143	0.00145	CcSEcCtD
Carbidopa—Dyspepsia—Capecitabine—colon cancer	0.00143	0.00145	CcSEcCtD
Carbidopa—Decreased appetite—Capecitabine—colon cancer	0.00141	0.00143	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Capecitabine—colon cancer	0.0014	0.00142	CcSEcCtD
Carbidopa—Fatigue—Capecitabine—colon cancer	0.0014	0.00142	CcSEcCtD
Carbidopa—Vision blurred—Methotrexate—colon cancer	0.0014	0.00142	CcSEcCtD
Carbidopa—Pain—Capecitabine—colon cancer	0.00139	0.00141	CcSEcCtD
Carbidopa—Constipation—Capecitabine—colon cancer	0.00139	0.00141	CcSEcCtD
Carbidopa—Nausea—Fluorouracil—colon cancer	0.00138	0.0014	CcSEcCtD
Carbidopa—Ill-defined disorder—Methotrexate—colon cancer	0.00138	0.00139	CcSEcCtD
Carbidopa—Anaemia—Methotrexate—colon cancer	0.00137	0.00139	CcSEcCtD
Carbidopa—Feeling abnormal—Capecitabine—colon cancer	0.00134	0.00136	CcSEcCtD
Carbidopa—Malaise—Methotrexate—colon cancer	0.00134	0.00136	CcSEcCtD
Carbidopa—Gastrointestinal pain—Capecitabine—colon cancer	0.00133	0.00135	CcSEcCtD
Carbidopa—Leukopenia—Methotrexate—colon cancer	0.00133	0.00135	CcSEcCtD
Carbidopa—Cough—Methotrexate—colon cancer	0.00129	0.00131	CcSEcCtD
Carbidopa—Urticaria—Capecitabine—colon cancer	0.00129	0.00131	CcSEcCtD
Carbidopa—Abdominal pain—Capecitabine—colon cancer	0.00128	0.0013	CcSEcCtD
Carbidopa—Body temperature increased—Capecitabine—colon cancer	0.00128	0.0013	CcSEcCtD
Carbidopa—Convulsion—Methotrexate—colon cancer	0.00128	0.0013	CcSEcCtD
Carbidopa—Chest pain—Methotrexate—colon cancer	0.00126	0.00128	CcSEcCtD
Carbidopa—Discomfort—Methotrexate—colon cancer	0.00125	0.00126	CcSEcCtD
Carbidopa—Confusional state—Methotrexate—colon cancer	0.00122	0.00124	CcSEcCtD
Carbidopa—Infection—Methotrexate—colon cancer	0.0012	0.00122	CcSEcCtD
Carbidopa—Hypersensitivity—Capecitabine—colon cancer	0.0012	0.00121	CcSEcCtD
Carbidopa—Thrombocytopenia—Methotrexate—colon cancer	0.00118	0.0012	CcSEcCtD
Carbidopa—Hyperhidrosis—Methotrexate—colon cancer	0.00117	0.00119	CcSEcCtD
Carbidopa—Asthenia—Capecitabine—colon cancer	0.00117	0.00118	CcSEcCtD
Carbidopa—Anorexia—Methotrexate—colon cancer	0.00115	0.00117	CcSEcCtD
Carbidopa—Pruritus—Capecitabine—colon cancer	0.00115	0.00117	CcSEcCtD
Carbidopa—Hypotension—Methotrexate—colon cancer	0.00113	0.00115	CcSEcCtD
Carbidopa—Diarrhoea—Capecitabine—colon cancer	0.00111	0.00113	CcSEcCtD
Carbidopa—Insomnia—Methotrexate—colon cancer	0.00109	0.00111	CcSEcCtD
Carbidopa—Paraesthesia—Methotrexate—colon cancer	0.00109	0.0011	CcSEcCtD
Carbidopa—Dyspnoea—Methotrexate—colon cancer	0.00108	0.00109	CcSEcCtD
Carbidopa—Somnolence—Methotrexate—colon cancer	0.00108	0.00109	CcSEcCtD
Carbidopa—Dizziness—Capecitabine—colon cancer	0.00107	0.00109	CcSEcCtD
Carbidopa—Dyspepsia—Methotrexate—colon cancer	0.00106	0.00108	CcSEcCtD
Carbidopa—Decreased appetite—Methotrexate—colon cancer	0.00105	0.00107	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Methotrexate—colon cancer	0.00104	0.00106	CcSEcCtD
Carbidopa—Fatigue—Methotrexate—colon cancer	0.00104	0.00106	CcSEcCtD
Carbidopa—Pain—Methotrexate—colon cancer	0.00103	0.00105	CcSEcCtD
Carbidopa—Vomiting—Capecitabine—colon cancer	0.00103	0.00105	CcSEcCtD
Carbidopa—Rash—Capecitabine—colon cancer	0.00102	0.00104	CcSEcCtD
Carbidopa—Dermatitis—Capecitabine—colon cancer	0.00102	0.00104	CcSEcCtD
Carbidopa—Headache—Capecitabine—colon cancer	0.00102	0.00103	CcSEcCtD
Carbidopa—Feeling abnormal—Methotrexate—colon cancer	0.000997	0.00101	CcSEcCtD
Carbidopa—Gastrointestinal pain—Methotrexate—colon cancer	0.000989	0.001	CcSEcCtD
Carbidopa—Nausea—Capecitabine—colon cancer	0.000965	0.000979	CcSEcCtD
Carbidopa—Urticaria—Methotrexate—colon cancer	0.000961	0.000974	CcSEcCtD
Carbidopa—Body temperature increased—Methotrexate—colon cancer	0.000956	0.000969	CcSEcCtD
Carbidopa—Abdominal pain—Methotrexate—colon cancer	0.000956	0.000969	CcSEcCtD
Carbidopa—Hypersensitivity—Methotrexate—colon cancer	0.000891	0.000904	CcSEcCtD
Carbidopa—Asthenia—Methotrexate—colon cancer	0.000868	0.00088	CcSEcCtD
Carbidopa—Pruritus—Methotrexate—colon cancer	0.000856	0.000868	CcSEcCtD
Carbidopa—Diarrhoea—Methotrexate—colon cancer	0.000828	0.000839	CcSEcCtD
Carbidopa—Dizziness—Methotrexate—colon cancer	0.0008	0.000811	CcSEcCtD
Carbidopa—Vomiting—Methotrexate—colon cancer	0.000769	0.00078	CcSEcCtD
Carbidopa—Rash—Methotrexate—colon cancer	0.000763	0.000773	CcSEcCtD
Carbidopa—Dermatitis—Methotrexate—colon cancer	0.000762	0.000773	CcSEcCtD
Carbidopa—Headache—Methotrexate—colon cancer	0.000758	0.000768	CcSEcCtD
Carbidopa—Nausea—Methotrexate—colon cancer	0.000718	0.000728	CcSEcCtD
